Starpharmaの配当

Starpharmaの配当は何ですか。

Starpharma Holdings Limitedの配当はAUD$0.00です。

配当の定義は何ですか。

配当率は、企業が1年以上株主に支払う1株当たりの配当金です。

The dividend rate is the total amount a company pays per share to a shareholders of its stock over a trailing one year. When the amount is calculated to be a ratio, the dividend rate identifies the dividends paid out per share. Dividends are when a company distributes a percentage of their profits to shareholders.

ASXのセクタHealth Careにおける配当の企業と比べるStarpharma

Starpharmaは何をしますか。

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

Starpharmaと類似の配当